Litcius/Paper detail

Ketamine for the treatment of acute pain

William K. Silverstein, David N. Juurlink, Jonathan S. Zipursky

2021Canadian Medical Association Journal14 citationsDOIOpen Access PDF

Abstract

Ketamine is a phencyclidine (PCP) derivative that exerts its effects primarily through N -methyl-d-aspartate receptor inhibition.[1][1] At low doses (0.1–0.3 mg/kg), ketamine produces mainly analgesia. Dissociative anesthesia and psychomimetic effects occur with higher doses (≥ 1.0 mg/kg). Low-

Topics & Concepts

KetaminePhencyclidineDissociativeAnesthesiaMedicinePharmacologyNMDA receptorReceptorInternal medicineAnesthesia and Pain ManagementTreatment of Major DepressionAnesthesia and Sedative Agents
Ketamine for the treatment of acute pain | Litcius